BEAT - שולי רווח נקי ממכירות HeartBeam Corp

BEAT (HeartBeam Corp) - סמל מסחרי של החברה

HeartBeam, Inc. generates revenue through the implementation of AIMIGo cloud-based 12-lead ECG monitoring. Its status as a leading developer of compact diagnostic systems strengthens cardiologist confidence. The net margin of commercial activities demonstrates financial efficiency, where 0.00 forms the current metric value. The development of the 3D-ECG ecosystem relies on unique software and obtaining FDA approvals to expand the user base.

רווחיות מכירות נקייה HeartBeam Corporation (BEAT): לתקופה 04.07.2022 - 19.11.2026

פילוחי נתונים אנליטיים מרוכזים עבור HeartBeam Corp (BEAT)

- מחיר מניה וקונצנזוס הערכת שווי:
הערכת שווי פונדמנטלית:HeartBeam Corporation - BEAT
מוצרים מוגמרים של HeartBeam Inc

HeartBeam, Inc. (BEAT) dominates the remote monitoring niche thanks to its unique 3D vectorcardiograph and inelastic patient demand. This net profit margin metric measures the portion of net income in every dollar of revenue, reflecting the overall efficiency of the business. It is critical for investors to track margin dynamics to identify any compression in profitability. A temporary decline may indicate strategic investments in development. Analysis of this chart allows for an assessment of the company's actual pricing power.